QualityStocksNewsBreaks – GolfLync Inc. Affirms Status as Go-to ‘Social Network for Golfers’

 GolfLync is the company behind the GolfLync app – a social network for matching golf games and players. “GolfLync just affirmed its status as the go-to ‘social network for golfers’ with over 200 5-star ratings on the Apple App Store. The ratings reflect the warm reception the app has received thus far, the level of thoughtfulness and detail that went into its development, and the real user value that GolfLync delivers to the growing community of golf enthusiasts around the country. Ratings are the way users find the top apps in a category, and GolfLync is significantly higher than the industry average, with sports apps averaging 3.97 and social networking apps posting a mere 3.73. GolfLync delivers an exceptional, tailored experience to golfers, which has been instrumental in amassing over 200 5-star reviews on the App Store,” a recent article reads. “The app is built to help golfers looking to grow their golf network, find other players with similar interests, and set up local groups and events, thus also growing the app’s community. With the popularity of golf having posted a steady rise in recent years, there is a growing demand for a platform that offers such features. GolfLync understands the demand, providing an app that meets users’ personal requirements, and thus driving a positive user experience.”

To view the full article, visit https://ibn.fm/2T5iO

About GolfLync Inc.

GolfLync is creating a new experience for golf lovers, connecting them with likeminded friends and groups with whom they can golf. Built to scale, GolfLync is ready to connect millions of players across the country and has groups forming in cities and at courses across America. Features include streaming feeds with social posts from golf players and groups across America, posting and finding tee times and, of course, chatting about golf! For more information, visit the company’s website at www.GolfLync.com.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Advancing the Use of AI to Power Financial Solutions

 

• FEXD acknowledges the recent big data boom that has introduced tech-driven solutions in the current financial services space
• AI, through its many forms, has proven to be a viable technology to integrate into the financial service space, a development that FEXD recognizes and welcomes
• Through its focus on the benefits of AI, the company is pushing its adoption while also pushing the conversation forward
• It is doing so while also exploring ways it can further develop this technology to address unmet mobile money needs, both in developing and industrialized countries and markets

Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is pushing the conversation around the use of artificial intelligence (“AI”) to power financial solutions, and for a good reason. As a company that understands the financial space, FEXD knows the potential that AI has to transform the space, and the value it brings in transforming an industry that has, for a long time, arguably lacked innovation.

FEXD acknowledges the recent big data boom that has disrupted banking. With big data, financial services organizations can offer more personalized services with a 360-degree view of the customer’s interaction with their brand. In addition, the morphing regulatory requirements have introduced tech-driven solutions geared toward addressing emerging challenges in the current financial systems. Competition has also forced many players to be innovative, challenging them to adopt tech to have the edge over their peers (https://ibn.fm/CBfuP).

AI, through its many forms, has proven to be a viable aspect of integrating into the financial service space, a development that FEXD recognizes and welcomes. With a growing range of applications, from simple chatbots to credit risk management tools, AI is finding its way to the core of financial solutions, and all stakeholders welcome it. So far, JPMorgan Chase, critical among other players in its space, has reported leveraging AI for fraud detection for its account holders. As a showcase of what AI is capable of, the bank has been able to implement a proprietary algorithm that detects fraud patterns, earning it high scores in both security and reliability (https://ibn.fm/35z4k).

This, along with other additional benefits, such as speeding up services, allowing financial institutions to make more informed risks, and creating avenues for better customer relationship management, point to the potential of AI in the financial space. By focusing on such, FEXD is pushing the AI conversation forward while exploring ways to develop this technology further to address unmet mobile money needs in developing and industrialized countries and markets. Through mergers and acquisitions with fintech pioneers, the company is establishing a global fintech ecosystem while advancing the development of proprietary technologies and applications designed to keep the company ahead of its peers. AI is a fundamental aspect of its innovations, and with this focus, the company is shedding light on its potential and value in the financial services space.

For more information, visit the company’s website at www.FintechEcoSys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to `

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.comw
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Control North America’s REE Supply Chain Amid Call For Economically and Environmentally Sound Approach

 

• Ford Motor Co. recently announced a $9.2 billion government loan for constructing three battery factories in the U.S.
• This is seen as a move that seeks to stir the growth of domestic EV battery manufacturing in the country in response to the growing demand for green technologies
• Ucore recognizes this demand, and through its transformative commercial-ready technology, RapidSX(TM), it looks to satisfy it and take control of the North American REE supply chain
• The company is well aware of the developments within its industry and is well positioned to take advantage of them and become the undisputed leader in the North American market

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company with a vision and plan to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry, is expected to benefit significantly given its focus on taking control of the North American rare earth elements (“REE”) supply chain. This follows the recent $9.2 billion government loan to Ford Motor Co. for constructing three battery factories, seeking to stir the growth of domestic EV battery manufacturing in the country (https://ibn.fm/Rbi73).

Considered the biggest government backing for a U.S. automaker since the bailouts back in the 2009 financial crisis, this loan is seen by many, including car manufacturers, as the government’s move to incentivize local companies to devise and explore ways to not only come up with technology to harness the natural resources already present in North America but also grow industries around it. The objective is to, ultimately, do away with the current supply chain, which is highly dependent on China.

Ucore, through its transformative commercial-ready technology, RapidSX(TM), looks to satisfy this need to become a leading advanced technology company with best-in-class metal separation products and services to the mining and mineral extraction industry. Its unique value proposition has seen the company differentiate itself from its peers, and its confidence in its technology has seen its aggressive expansion and investment into the development of a heavy and light rare-earth processing facility in Louisiana.

“We are more confident than ever that Ucore’s planned rare earth separation facility in Louisiana will be a critical component of a North American rare earth supply chain,” noted Pat Ryan, Ucore’s Chairman, and CEO.

RapidSX(TM) combines the time-proven chemistry of conventional solvent extraction (“SX”) with a new column-based platform, significantly reducing time to completion and plant footprint. This technology also offers the potential to lower capital and operating costs, resulting in a more efficient process than the industry standard. Its scalable and modular nature also makes it ideal for the country’s current approach of ramping up its REE production capacity. In addition, its feedstock adaptability makes it readily configurable for separating any light or heavy REE (“LREE, HREE”) using the same equipment.

Ford Motor Co. has already committed to a $3.5 billion investment in an electric-vehicle battery plant in Michigan. Though controversial, the company has noted that it will operate with technology and support from China’s Contemporary Amerex Technology Co. Ltd., describing it as a “licensing” that will allow its engineers to “gain that knowledge so we can eventually do it ourselves” (https://ibn.fm/tDyxV).

With such steps and massive investments being made, it is only a matter of time before North America catches up, cuts into China’s advantage in EV batteries, and takes control of the global REE supply chain. Ucore is well aware of these developments and is ready to take advantage of them.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to `

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.comw
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Offering to Include Boutique End-to-End CDMO Services

 

• BiondVax’s CDMO services allow the company to partner with pharmaceutical companies to provide contract-based drug development and manufacturing services
• BiondVax showcased its boutique end-to-end CDMO offering at the annual Biomed Conference in Tel Aviv in May
• BiondVax’s cGMP biologics manufacturing facility in Jerusalem is fully equipped with state-of-the-art CDMO capabilities
• The expansion of CDMO services will augment revenue and expand pharma contacts while still maintaining BiondVax’s core focus of NanoAb therapies for significant indications like COVID-19, psoriasis, asthma, and more

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently showcased the expansion of its service to begin offering services as a contract development and manufacturing organization (“CDMO”). These CDMO services will allow BiondVax to partner with pharmaceutical companies to provide contract-based drug development and manufacturing services, leveraging its Good Manufacturing Practices (“GMP”) biologics manufacturing facility in Jerusalem.

In May, BiondVax showcased its boutique end-to-end CDMO services and expertise at a leading conference for international Life Science and HealthTech industries, the Biomed Conference, in Tel Aviv. The company’s CDMO services are designed to meet the needs of pharmaceutical and biotechnology companies of all sizes, with a commitment to providing customers with the highest levels of quality and service.

BiondVax’s CDMO offers a comprehensive range of services and assets, including:

• cGMP manufacturing of biologics at FDA and EMA standards
• State-of-the-art laboratories for manufacturing process development and scale-up
• Deep pharma experience and leadership to help accelerate products forward

The company’s cGMP manufacturing suites include clean rooms for upstream fermentation, downstream purification, labeling and visual inspection. It has previously passed the required audits for Phase 3 clinical trial production and more – which can be found in BiondVax’s CDMO literature. (https://ibn.fm/25F09).

“Offering CDMO services allows us to use our state-of-the-art facility to generate revenues and offset certain fixed costs while still using it for our NanoAbs,” BiondVax CEO Amir Reichman said in a year-end letter to stakeholders. In a March interview, he also said his team has proven experience with running pre-clinical trials, clinical trials, chemistry, manufacturing and controls [CMC], quality assistance — with everything working like an oiled machine (https://ibn.fm/b9ZHc). “Also, the capacity and the capabilities are there.”

BiondVax’s NanoAbs, also known as VHH-antibodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies. These advantages include stability at high temperatures, superior binding affinity, more effective and convenient routes of administration, and efficient production. The company is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

BiondVax’s development of NanoAb therapies addresses diseases that are currently underserved by current treatments, with large growing markets. In addition to COVID-19, the growing market outlook for asthma and psoriasis supports BiondVax’s focus on creating efficient therapies for patients in these indications.

Recent company statements on its quarterly financial results noted that it has already begun R&D activities for an innovative NanoAb platform targeting immune system cytokines. The drug candidate development process will focus on cytokines such as IL-17 for their potential in treating psoriasis and psoriatic arthritis.

Adding the CDMO services will keep the team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb focus – targeting COVID-19, psoriasis, asthma, and more.

For more information, visit the company’s website at www.BiondVax.com.

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to `

QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.comw
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php